EDGAR Filing Documents for 0001193125-18-153676

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-18-153676

Filing Date

2018-05-07

Accepted

2018-05-07 08:52:08

Documents

Effectiveness Date

2018-05-07

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d583918ds8.htm	S-8	64594
2	EX-5.1	d583918dex51.htm	EX-5.1	13086
3	EX-23.1	d583918dex231.htm	EX-23.1	1838
4	EX-23.2	d583918dex232.htm	EX-23.2	1757
5	EX-24.2	d583918dex242.htm	EX-24.2	1746
6	GRAPHIC	g583918dsp14.jpg	GRAPHIC	2302
7	GRAPHIC	g583918page15.jpg	GRAPHIC	1727
	Complete submission text file	0001193125-18-153676.txt		89859

Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544

Business Address 510-240-6000

Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-224700 | Film No.: 18809788
SIC: 2834 Pharmaceutical Preparations